RNTX Q1 2026 Earnings Narrowed Loss Beats Estimates as Rein Therapeutics Advances Pipeline CAC Q1 2026 Earnings EPS Beats Estimates Amid Stable Operations Outlook Therapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Surges 29 HWKN Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain NKTX Q1 2026 Earnings Narrowing Loss and Stable Stock Performance RILYL Q1 2024 Earnings Preferred Stock Reports Negative EPS Amid Market Challenges